Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Actavis launches generic anxiety drug in US
Actavis said distribution of the product would commence in coming weeks. Alprazolam ER tablets are the generic equivalent of Pfizer's Xanax XR tablets, will be available in 0.5mg,
Actavis said distribution of the product would commence in coming weeks. Alprazolam ER tablets are the generic equivalent of Pfizer's Xanax XR tablets, will be available in 0.5mg,
Johnson & Johnson voluntarily disclosed the information to the US Department of Justice and the US Securities and Exchange Commission. Johnson & Johnson said the actions were contrary
The companies believes this is a major breakthrough in reducing the cost of goods in biopharmaceutical production A key objective of their development venture was to achieve yields
The FDA indicated that Advancis’ application was not sufficiently complete in that it did not include a proposed commercial batch record or a detailed commercial process description with
The agency commented that there were about 28 cases of infants suffering from these side effects but that it was not immediately apparent if the vaccine was the
The trial will enroll 15 chronically infected patients who have never received any therapy for their condition. The trial’s primary endpoint is safety and secondary endpoints are immunological
Hemospan is the first oxygen therapeutic specifically engineered to target oxygen delivery to tissues. No similar therapeutic agents are currently on the market in Europe or the US.
The new agreement expands the collaboration that has been going on for the last three years, and roughly doubles the FTE effort at ChemDiv’s Chemical Diversity Research Institute
The primary objective of the phase I trial was to evaluate the safety and tolerability of escalating doses of BL-1020. The study results showed that BL-1020 was well
Somaxon also said that the FDA agreed that Silenor does not appear to cause cancer or induce genetic mutations and therefore assessment of these side effects would not